Back to Search

ALDX

Aldeyra Therapeutics, Inc.
Data: 2026-09-04
$1.48
Price
0.00%
Change
$5.93
52W High
$1.07
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Quick Stats
Sep 04, 2026

55.9

AI Score

BUY

0.64

Volume Ratio

TBA

Next Earnings

11

+ve Days (30d)

14

-ve Days (30d)

ALDX Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

ALDX Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

ALDX Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ALDX Daily Out of Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ALDX Daily In the Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ALDX Most Active Options by Volume(near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
ALDX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ALDX Stock Summary

Last updated Sep 04, 2026

ALDX is currently trading at $1.48, positioned below its 200-day moving average of $3.02, suggesting bearish momentum. The stock has a 52-week range of $1.07 to $5.93.

Technical Analysis: The 50-day moving average stands at $1.7, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.18, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.193, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ALDX at 55.9/100 with a BUY recommendation.

ALDX (Aldeyra Therapeutics, Inc.) Indicators

Last updated Sep 04, 2026

Indicator Value
RSI(14) 40.18
CMF (20) -0.193
ROC (10) -2.632
ADX (14) 24.385
Indicator Value
MACD (12,26,9) -0.043
AROONOSC (14) -64.286
WILLAMS %R (14) -82.759
MFI (14) 41.63

Aldeyra Therapeutics, Inc. is below both the 50 Day and 200 Day SMA which is considered Bearish.

ALDX Moving Averages Analysis

ALDX (Aldeyra Therapeutics, Inc.) Simple Moving Averages

Moving Averages are last updated Sep 04, 2026

Days MA
10 1.51
20 1.52
30 1.54
50 1.7
100 1.71
200 3.02

ALDX Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 89.3 million
Earnings/Share ($) -0.38
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.34
EPS Estimate Next Year ($) -0.275
WallStreet Target Price ($) 6.60
Most Recent Quarter

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.